SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Reflections on the evolution of health technology assessment in Europe
16 references·1 citing·41 second hop
Reflections on the evolution of health technology assessment in Europe (2012)Reflections on the evolution of health te…Health Technology Assessment and Health Policy-Making in Europe: Current Status, Challenges and Potential (2009)Health Technology Assessment …Comparative Effectiveness Research and Evidence‐Based Health Policy: Experience from Four Countries (2009)Comparative Effectiveness Res…Key principles for the improved conduct of health technology assessments for resource allocation decisions (2008)Key principles for the improv…Ensuring value for money in health care: the role of health technology assessment in the European Union (2008)Ensuring value for money in h…Understanding the limited impact of economic evaluation in health care resource allocation: A conceptual framework (2006)Understanding the limited imp…Framework for describing and classifying decision-making systems using technology assessment to determine the reimbursement of health technologies (fourth hurdle systems) (2006)Framework for describing and …Deliberative processes and evidence-informed decision making in healthcare: do they work and how might we know? (2006)Deliberative processes and ev…Bringing ‘the public’ into health technology assessment and coverage policy decisions: From principles to practice (2006)Bringing ‘the public’ into he…Priority setting in health – a political economy perspective (2005)Priority setting in health – …National Institute for Clinical Excellence and its value judgments (2004)National Institute for Clinic…HTA 101 INTRODUCTION TO HEALTH TECHNOLOGY ASSESSMENT (2004)HTA 101 INTRODUCTION TO HEALT…Health technology assessment and its influence on health-care priority setting (2004)Health technology assessment …Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysis (2004)Does NICE have a cost‐effecti…Organized Interests and American Democracy. By Kay Lehman Schlozman and John T. Tierney. (New York: Harper & Row, 1986. Pp. xix + 448. $12.00, paper.) (1986)Organized Interests and Ameri…The Logic of Collective Action. (1966)The Logic of Collective Actio…The Logic of Collective Action (1965)The Logic of Collective Action(De-)assetizing pharmaceutical patents: Patent contestations behind a blockbuster drug (2021)(De-)assetizing pharmaceutica…The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)Assessing the quality of reports of randomized clinical trials: Is blinding necessary? (1996)Meta-analysis of Observational Studies in Epidemiology A Proposal for Reporting (2000)Health Technology Assessment: Lessons Learned from Around the World—An Overview (2009)Identifying existing health care services that do not provide value for money (2009)Using health technology assessment for informing coverage decisions in Thailand (2012)Health Care Needs and Distributive Justice (1983)Cost-Value Analysis in Health Care (1999)The global challenge of health care rationing (2000)End-user involvement in health technology assessment (HTA) development: A way to increase impact (2005)Exploring the social value of health‐care interventions: a stated preference discrete choice experiment (2008)The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies (1999)Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold (2008)International survey on willingness‐to‐pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? (2009)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)EuroQol: the current state of play (1996)Decision Making in Health and Medicine: Integrating Evidence and Values (2001)Delivering affordable cancer care in high-income countries (2011)The Concept of Representation (1967)The Concept of Representation, by Hanna F. Pitkin (1969)Participation and Democratic Theory (1970)The Role of Economic Evidence in Canadian Oncology Reimbursement Decision-Making: To Lambda and Beyond (2008)Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA (2018)Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward (2019)Cost-Effectiveness in Health and Medicine (1996)Methods for the Economic Evaluation of Health Care Programmes (2005)Methods for the economic evaluation of health care programmes, 3rd ed (2006)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (2013)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (2013)Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending (2017)Conceptualizing Political Opportunity (2004)Protest and Political Opportunities (2004)From Incivility to Outrage: Political Discourse in Blogs, Talk Radio, and Cable News (2011)Introduction: epistemic communities and international policy coordination (1992)Social Theory of International Politics (1999)Increasing Returns, Path Dependence, and the Study of Politics (2000)Role of patient and public participation in health technology assessment and coverage decisions (2011)Social values in health priority setting: a conceptual framework (2012)Generating comparative evidence on new drugs and devices after approval (2020)Why do Some Countries Produce So Much More Output Per Worker than Others? (1999)Varieties of Capitalism (2001)
this work references cited by second hop

References

  • 1965The Logic of Collective Action14,183 cited
  • 1966The Logic of Collective Action.11,364 cited
  • 2004National Institute for Clinical Excellence and its value judgments767 cited
  • 2004Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysis710 cited
  • 1986Organized Interests and American Democracy. By Kay Lehman Schlozman and John T. Tierney. (New York: Harper & Row, 1986. Pp. xix + 448. $12.00, paper.)590 cited
  • 2008Key principles for the improved conduct of health technology assessments for resource allocation decisions489 cited
  • 2006Bringing ‘the public’ into health technology assessment and coverage policy decisions: From principles to practice245 cited
  • 2004HTA 101 INTRODUCTION TO HEALTH TECHNOLOGY ASSESSMENT185 cited
  • 2009Comparative Effectiveness Research and Evidence‐Based Health Policy: Experience from Four Countries160 cited
  • 2004Health technology assessment and its influence on health-care priority setting149 cited
  • 2009Health Technology Assessment and Health Policy-Making in Europe: Current Status, Challenges and Potential137 cited
  • 2006Deliberative processes and evidence-informed decision making in healthcare: do they work and how might we know?137 cited
  • 2008Ensuring value for money in health care: the role of health technology assessment in the European Union120 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2006
Understanding the limited impact of economic evaluation in health care resource allocation: A conceptual framework
116 cited
  • 2005Priority setting in health – a political economy perspective103 cited
  • 2006Framework for describing and classifying decision-making systems using technology assessment to determine the reimbursement of health technologies (fourth hurdle systems)101 cited
  • Cited by

    • 2021(De-)assetizing pharmaceutical patents: Patent contestations behind a blockbuster drug52 cited